west virginia tirzepatide lawsuit CVS Caremark stopped covering a GLP-1 for obesity. Now there's a Judge finds for 3 major
Description
Incretins are endogenous compounds, including GLP-1, that improve glycemic control once released into the circulation
In one trial, nausea and diarrhea were the most common side effects
doi:10.1186/s12933-021-01412-5 Frias JP, Davies MJ, Rosenstock J, et al
Insulin sensitivity improves in tissues that were previously resistant
